Skip to main content

Perspectives

Perspectives
Thinking About 2030
David B. Nash, MD, MBA
David B. Nash, MD, MBA
Read More
Online First
Perspectives
Leading Population Health Efforts: The Power of Vowels
Richard G. Stefanacci, DO, MGH, MBA, AGSF, Anindita Banerjee, BSc, MBA
Richard G. Stefanacci, DO, MGH, MBA, AGSF; Anindita Banerjee, BSc, MBA
Read More
Online First
Perspectives
A Call for Innovation: We Need to Go Off Road to Ensure Medication Adherence Amid COVID-19
Javier Gonzalez, PharmD
Javier Gonzalez, PharmD
Read More
Perspectives
What Is Your IQ(VIA)?
David B. Nash, MD, MBA
David B. Nash, MD, MBA
Read More
Perspectives
The Dirty Dozen Redux
David B. Nash, MD, MBA
David B. Nash, MD, MBA
Read More
Perspectives
Pandemic Posting
David B. Nash, MD, MBA
David B. Nash, MD, MBA
Read More
Online Only
Perspectives
Politics and Healthcare: Drug Pricing Dynamics Leading Up to the 2020 Election
Gary Branning, MBA, Kathryn Hayes, BA
Gary Branning, MBA; Kathryn Hayes, BA
Read More
Perspectives
Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?
Karen Geary
Karen Geary
Read More
Perspectives
UnHealthcare
David B. Nash, MD, MBA
David B. Nash, MD, MBA
Read More
Perspectives, Infectious Diseases
Are Nursing Homes COVID-19’s “Contaminated Wells,” and Will They Receive Additional Resources?
Bruce S. Pyenson, FSA, MAAA, David C. Grabowski, PhD
Bruce Pyenson, FSA, MAAA, and David C. Grabowski, PhD
Read More
Page 2 of 18
Results 11 - 20 of 173